Navigation Links
RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite
Date:1/4/2012

DES MOINES, Iowa, Jan. 4, 2012 /PRNewswire/ -- Pharmaceutical marketers who need to calibrate multi-channel marketing and sales resources and spending to maximize ROI have limitless questions. SyntheSight™, a new proprietary pharmaceutical multi-channel marketing optimization methodology developed by RMi with a patent-pending IntelliScore™, provides actionable insights and ad hoc reporting to help brand leaders find answers.

SyntheSight features two primary components: OptiView™, an online dashboard environment, provides an action-oriented view of program performance and recommendations to optimize results; and IntelliScore features a real-time customer interaction quotient reflecting engagement and facilitating investment optimization for ROI.

"The pharmaceutical industry is struggling with accountability of multi-channel marketing spending and reliably predicting and measuring ROI," said Andrea Westmeyer, RMi president. "SyntheSight methodology allows our clients to carefully calibrate their brand marketing and sales functions based on real measurable marketing insights, and to better leverage that knowledge for increased brand sales, or throughout their enterprise or franchise."

RMi client Jay Appel, director of physician relationship marketing at Amgen, has had SyntheSight in test use for over one year. "This is the future of our business," he said. "From first impression to engagement to behavioral change, the SyntheSight methodology enables us to effectively evaluate key tactics as we optimize our multi-channel marketing."

According to Westmeyer, SyntheSight users engaged in multi-channel marketing programs have 51 percent greater physician engagement than programs utilizing sales alone. By month six of a SyntheSight –managed, multi-channel marketing program, 62 percent of targets were engaged with one or more program elements. On average, multi-channel marketing programs utilizing SyntheSight have produced an 11.8 percent sales lift for RMi clients, she noted.

Westmeyer said SyntheSight methodology offers marketers a real-time view of their customers to drive sales for a single brand, or to better leverage data insights to benefit multiple brands in an enterprise. According to Westmeyer, RMi's clients are using SyntheSight to fill the "actionable insights knowledge gaps" in their marketing organizations to help answer questions, such as:

  • Was marketing spend optimized? (Right target, message, choice of tactics? Positive ROI?)
  • What was the sales lift from marketing spend? Which tactics worked best?
  • Can I predict or forecast lost sales?
  • Can we leverage category insights into successful physician engagement from one brand to another?

"Breaking barriers to physician engagement requires cutting through the clutter with marketing and sales programs carefully calibrated to optimize sales growth, while controlling costs," Westmeyer concluded. "SyntheSight methodology in practice produces real. measurable. insight.™ which offers scalable solutions for any brand, franchise or enterprise marketing to HCPs."

About RMi

RMi is a peerless team of HCP marketing engagement specialists who break barriers, clutter and records with best-of-breed measurement and optimization strategies and technology to engage targets and increase sales. SyntheSight™, RMi's proprietary pharmaceutical industry multichannel optimization methodology, provides nearly real-time actionable insights to optimize sales and marketing spend. To learn more visit http://sales.rmarketing.com for a short video and capabilities overview.

CONTACT:

John Dutcher, APR, Dutcher & Associates, L.L.C.

515/334-3464; dna@qwestoffice.net

Or

Andrea Westmeyer, RMi

917/749-6875; awestmeyer@Rmarketing.com

 

™ SyntheSight, OptiView and IntelliScore are registered trademarks of RMi.

™ real. measurable. insight. is a registered trademark of RMi.


'/>"/>
SOURCE RMi
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. Dr. Dello Russo Introduces the New EYE-Q Lasik
3. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
4. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
5. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
6. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
7. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
8. Siemens Introduces New Standard of Care for Breast Ultrasound
9. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
10. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
11. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... , May 6, 2016  Hill-Rom Holdings, Inc. (NYSE: ... of Directors declared a fiscal year 2016 third quarter ... percent increase over the amount paid a year ago. ... record as of the close of business on June 10, ...    Hill-Rom is a leading global medical technology ...
(Date:5/5/2016)... International plc (NASDAQ: ENDP ) (TSX: ENL) today ... president of Allergan, Inc. and current CEO of Chase Pharmaceuticals ... TPG Capital, to its Board of Directors. The appointments are ... recently embarked on a search for new Board members who ... and Todd are experienced leaders, and we are extremely pleased ...
(Date:5/5/2016)... Research and Markets has announced the addition ... EU Markets"  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... the current Positron Emission Tomography (PET) scanner and cyclotron install ... includes France , Germany ... and the United Kingdom . Along ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... 06, 2016 , ... The Price Agency in Birmingham, AL ... assist the people of their local community. The agency pledges to select a ... Their desire is to bring awareness to important local causes with fundraising and ...
(Date:5/6/2016)... ... May 06, 2016 , ... The joy associated with Mother’s Day is mixed with ... neonatal intensive care units (NICUs) across the country. For the first time ever, the ... honor these women who spend their Mother’s Day beside a crib surrounded by lifesaving equipment ...
(Date:5/6/2016)... ... ... US Sports Camps has collaborated with State Rugby Organization (SRO), Rugby Oregon, ... Employing world-class rugby figures, including former Team USA players and college coaches, this program ... match play, fitness and more. , “US Sports Camps is honored to be working ...
(Date:5/6/2016)... ... May 06, 2016 , ... Bluvault ( Bluvault Inc. ... offering for global clients of Coupa ( Coupa Software ) and other Cloud ... is a key component in the suite of innovative implementation services offered by ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... reduce fat areas around the body, is the most popular among body sculpting ... released make perfect sense to cosmetic surgeon Dr. Richard Buckley, medical director of ...
Breaking Medicine News(10 mins):